The surgical management of pleural mesothelioma (PM) can be divided into diagnostic,
staging, palliation, and cytoreductive surgery. In the cytoreductive surgical setting, the …

Pleural mesothelioma (PM) is a rare and aggressive disease that arises from the mesothelial
cells lining the pleural cavity. Approximately 80% of PM patients have a history of asbestos …

Simple Summary Malignant pleural mesothelioma (MPM) is an aggressive tumor with
implacable prognosis. It commonly harbors loss-of-function mutations in BAP1, NF2 …

Objective: We hypothesize that recurrence following pleurectomy decortication (PD) is
primarily local. We explored factors associated with tumor recurrence patterns, disease-free …

Pleural mesothelioma is a rare disease with a dismal prognosis and few therapeutic options.
Until recently the median overall survival for a pleural mesothelioma patient was up to 2 …

Malignant pleural mesothelioma (MPM) has a rich stromal component containing
mesenchymal fibroblasts. However, the properties and interplay of MPM tumor cells and …

抄録 背景. アスベスト曝露関連疾患である悪性胸膜中皮腫は免疫チェックポイント阻害薬の登場
など治療選択肢が**年増えてはいるが, 依然として予後不良の疾患である. 一方で長期生存例が …

Mesothelioma is a malignancy of the pleura, less frequently the peritoneum, rarely the
pericardium or tunica vaginalis. Most mesotheliomas are very aggressive and resistant to …

Malignant mesothelioma (MM) is an aggressive neoplasia arising from mesothelial cells that
line serous cavities, such as pleura, peritoneum, pericardium, and vaginal tunic. It is defined …

Mesothelioma originates from the mesothelial cells that form the pleura and the peritoneum.
Mesothelial cells are the last remnant of the mesoderm that covers the celomic cavity, which …